This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Henkel, Olaplex likely to cite recent market entry to address US product overlaps

By Ilana Kowarski ( May 14, 2026, 16:53 GMT | Comment) -- Hair treatment creators Henkel and Olaplex are likely to cite recent market entry and frequent innovation within the hair therapeutics industry to assuage US regulatory concerns about their deal. The sector for hair treatment serums and masks is moderately concentrated; however, antitrust officials could have questions if they look at narrow markets, such as hair bond maximization, where Olaplex is one of the market leaders. Olaplex has an especially high market share in the segment focused on relinking sulfur atoms in hair keratin proteins.Hair treatment creators Henkel and Olaplex are likely to cite recent market entry and frequent innovation within the hair therapeutics industry to assuage US regulatory concerns about their deal....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login